Orthopaedic applications of gene therapy: From concept to clinic

Clinical Orthopaedics and Related Research

Volumn 375, Issue , 2000, Pages 324-337

  Kang, R ^a   Ghivizzani, S C ^b   Muzzonigro, T S ^a   Herndon, J H ^b   Robbins, P D ^a   Evans, C H ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ARTICLE; FEMALE; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HUMAN; OSTEOARTHRITIS; OSTEOGENESIS IMPERFECTA; OSTEOPOROSIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; ANIMAL; ARTHROPATHY; BONE DISEASE; DISEASE MODEL; GENE VECTOR; REVIEW;

ANIMALS; ARTHRITIS, RHEUMATOID; BONE DISEASES; DISEASE MODELS, ANIMAL; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; JOINT DISEASES; OSTEOARTHRITIS;

EID: 0034119863     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-200006000-00039     Document Type: Article

References (77)

1. 1 and heat shock protein 70 gene transduction. J Rheumatol 24:1787-1795, 1997.
2. Arend WP, Malyak M, Guthridge CJ, et al: Interleukin-1 receptor antagonist: Role in bology. Ann Rev Immunol 16:27-55, 1998.
3. Bakker AC, Joosten LAB, Arntz OJ, et al: Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee. Arthritis Rheum 40:893-900, 1997.
4. Balk M, Bray J, Day C, et al: Effect of rhBMP-2 on the osteogenic potential of bone marrow stromal cells from osteogenesis imperfecta mouse (oim). Bone 21:7-15, 1997.
5. Baltzer AWA, Lattermann C, Weiss K, et al: Genetic enhancement of fracture repair: Evaluation of ad-BMP-2 in a lapine femoral defect model. Gene Ther In Press.
6. Baltzer AWA, Latterman C, Whalen J, et al: A gene transfer approach to accelerating bone healing: Evaluation of gene expression in a New Zealand White rabbit model. Knee Surg Sport Traumatol Arthrosc 7:197-202, 1999.
7. Bandara G, Mueller GM, Galea-Lauri J, et al: Intraarticular expression of biologically active interleukin-1 receptor antagonist protein by ex vivo gene transfer. Proc Natl Acad Sci USA 90:10764-10768, 1993.
8. Bandara G, Robbins PD, Georgescu HI, et al: Gene transfer to synoviocytes: Prospects for gene treatment for arthritis. DNA Cell Biol 11:227-231, 1992.
9. Baragi VM, Renkiewicz RR, Qui L, et al: Transplantation of adenovirally transduced allogeneic chondrocytes into articular cartilage defects in vivo. Osteoarthritis Cartilage 5:275-282, 1997.
10. Boggs SS, Patrene KD, Mueller GM, et al: Prolonged systemic expression of human IL-1 receptor antagonist protein in sera of lethally irradiated mice reconstituted with hematopoietic stem cells transduced with a retrovirus containing the IL-1ra gene. Gene Ther 2:632-638, 1995.
11. Bresnihnan B, Alvaro-Garcia JM, Cobby M, et al: Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum 41:2196-2204, 1998.
12. Campion GV, Lebsack ME, Lookabaugh J, et al: Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Arthritis Rheum 39:1092-1101, 1996.
13. Caplan AI: Mesenchymal stem cells. J Orthop Res 9:641-650, 1991.
14. Doughty LA, Patrene KD, Evans CH, et al: Constitutive systemic expression of IL-1Ra or soluble TNF receptor by genetically modified hematopoietic cells suppresses LPS induction of IL-6 and IL-10. Gene Ther 4:252-257, 1997.
15. Elliott MJ, Maini RN, Feldmann M, et al: Randomised, double blind comparison of a chimaeric: Monoclonal antibody to tumor-necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet 344:1105-1110, 1994.
16. Evans CH, Bandara G, Robbins PD, et al: Gene Therapy for Ligament Healing. In Jackson DW (ed). The Anterior Cruciate Ligament: Current and Future Concepts. New York, Raven Press 419-422, 1993.
17. Evans CH, Ghivizzani SC, Kang R, et al: Gene therapy for rheumatic diseases. Arthritis Rheum 42:1-16, 1999.
18. Evans CH, Ghivizzani SC, Robbins PD: A 1998 status report on orthopaedic gene therapy. Curr Opin Orthop 9:75-80, 1998.
19. Evans CH, Ghivizzani SC, Robbins PD: Blocking cytokines with genes. J Leuk Biol 64:55-61, 1998.
20. Evans CH, Robbins PD: Possible orthopaedic applications of gene therapy. J Bone Joint Surg 77A:1103-1114, 1995.
21. Evans CH, Robbins PD: Potential treatment of osteoarthritis by gene therapy. Rheum Dis Clin North Am 25:333-344, 1999.
22. Evans CH, Robbins PD: Genetically augmented tissue engineering of the musculoskeletal system. Clin Orthop 5367:S410-S418, 1999.
23. Evans CH, Robbins PD: Gene therapy in orthopaedics. Orthop Nurs 19:16-22, 2000.
24. Evans CH, Robbins PD, Ghivizzani SC, et al: Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis. Hum Gene Ther 7:1261-1280, 1996.
25. Fang J, Zhu YY, Smiley E, et al: Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc Natl Acad Sci USA 93:5753-5758, 1996.
26. Geiler T, Kriegsmann J, Keyszer G, et al: A new model for rheumatoid arthritis generated by engraftment of rheumatoid synovial tissue and normal human cartilage into SCID mice. Arthritis Rheum 37:1664-1671, 1994.
27. Gerich TG, Kang R, Fu FH, et al: Gene transfer to the rabbit patellar tendon: Potential for genetic enhancement of tendon and ligament healing. Gene Ther 3:1089-1093, 1996.
28. Ghivizzani SC, Kang R, Georgescu HI, et al: Constitutive intraarticular expression of human IL-1β following gene transfer to rabbit synovium produces all major pathologies of human rheumatoid arthritis. J Immunol 159:3604-3612, 1997.
29. Ghivizzani SC, Kang R, Muzzonigro T, et al: Gene therapy for arthritis - Treatment of the first three patients. Arthritis Rheum 40(Suppl):S223, 1998. Abstract.
30. Ghivizzani SC, Lechman ER, Kang R, et al: Direct adenoviral-mediated gene transfer of IL-1 and TNF-α soluble receptors to rabbit knees with experimental arthritis has local and distal antiarthritic effects. Proc Natl Acad Sci USA 95:4613-4618, 1998.
31. Ghivizzani SC, Lechman ER, Tio C, et al: Direct retroviral mediated gene transfer to the synovium of the rabbit knee: Implications for arthritis gene therapy. Gene Ther 4:977-982, 1997.
32. Goldstein SA, Bonadino J: Potential role for direct gene transfer in the enhancement of fracture healing. Clin Orthop 355 (Suppl):S154-S162, 1998.
33. Goto H, Shuler FD, Lamsam C, et al: LacZ gene transfer to meniscus. J Bone Joint Surg 81A:918-925, 1999.
34. 1 gene. Osteoarthritis Cartilage In Press.
35. Granowitz EV, Porat R, Mier JW, et al: Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans. Cytokine 4:353-360, 1992.
36. Herndon JH, Robbins PD, Evans CH: Arthritis: Is the cure in your genes? J Bone Joint Surg 81A:152-157, 1999.
37. Hildebrand KA, Deie M, Allen CR, et al: Early expression of marker genes in the rabbit medial collateral and anterior cruciate ligament: The use of different viral vectors and the effects of injury. J Orthop Res 17:37-42, 1999.
38. Hung GL, Galea-Lauri J, Mueller GM, et al: Suppression of intraarticular responses to interleukin-1 by transfer of the interleukin-1 receptor antagonist gene to synovium. Gene Ther 1:64-69, 1994.
39. Jaffurs JD: Effects of adenoviral-mediated transfer of the human inos gene on the metabolism of articular cells in vitro and on inflammation in vivo. PhD Thesis. Pittsburgh, PA, University of Pittsburgh 1999.
40. Kang R, Marui T, Ghivizzani SC, et al: Ex vivo gene transfer to chondrocytes in full-thickness articular cartilage defects: A feasibility study. Osteoarthritis Cartilage 5:139-143, 1997.
41. Klein TM, Wolf ED, Wu R, Sanford JC: High-velocity microprojectiles for delivering nucleic acids into living cells. Nature 327:70-73, 1987.
42. Lechman ER, Jaffurs D, Ghivizzani SC, et al: Direct adenoviral gene transfer of vIL-10 to rabbit knees with experimental arthritis ameliorates disease in both injected and contralateral knees. J Immunol 163:2202-2208, 1999.
43. Lee RJ, Huang L: Lipidic vector systems for gene transfer. Crit Rev Ther Drug Carrier Syst 14:173-206, 1997.
44. Lewthwaite J, Blake SM, Hardingham TE, et al: The effect of recombinant human interleukin-1 receptor antagonist on the induction phase of antigen-induced arthritis in the rabbit. J Rheumatol 21:452-467, 1997.
45. Lieberman JR, Le LQ, Wu L, et al: Regional gene therapy with a BMP-2 producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents. J Orthop Res 16:330-339, 1998.
46. Lou J, Kubota H, Hotokezaka S, et al: In vivo gene transfer and overexpression of focal adhesion kinase (pp. 125 FAK) mediated by recombinant adenovirus-induced tendon adhesion formation and epiteron cell change. J Orthop Res 15:911-918, 1997.
47. Lou J, Manske PR, Aoki M, et al: Adenovirus-mediated gene transfer into tendon and tendon sheath. J Orthop Res 14:513-517, 1996.
48. Makarov SS, Olsen JC, Johnston WN, et al: Suppression of experimental arthritis by gene transfer of interleukin-1 receptor antagonist cDNA. Proc Natl Acad Sci USA 93:402-406, 1996.
49. McCarthy M: Gene therapy for rheumatoid arthritis starts clinical trials. Lancet 348:323, 1996.
50. Montgomery DL, Shiver JW, Leander KR, et al: Heterologous and homologous protection against influenza A by DNA vaccination: Optimization of DNA vectors. DNA Cell Biol 12:777-783, 1993.
51. Moreland LW, Baumgartner SW, Schiff MH, et al: Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med 337:141-147, 1997.
52. Moreland LW, Heck LW, Koopman WJ: Biologic agents for treating rheumatoid arthritis. Concepts and progress. Arthritis Rheum 40:397-409, 1997.
53. Müller-Ladner U, Evans CH, Franklin BN, et al: Gene transfer of cytokine inhibitors into human synovial fibroblasts and the SCID mouse. Arthritis Rheum 42:490-497, 1999.
54. Müller-Ladner U, Roberts CR, Franklin BN, et al: Gene transfer of TNF-α receptor p55 into human synovial fibroblasts and implantation into the SCID mouse. Arthritis Rheum 39(Suppl):S1677, 1996. Abstract.
55. Müller-Ladner U, Roberts CR, Franklin BN, et al: Human IL-1Ra gene transfer into human synovial fibroblasts is chondroprotective. J Immunol 158:3492-3498, 1997.
56. Nakamura N, Horibe S, Matsuume N, et al: Transient introduction of a foreign gene into healing rat patellar ligament. J Clin Invest 97:226-231, 1996.
57. Nakamura N, Shino K, Matsuume T, et al: Early biological effect of in vivo gene transfer of platelet-derived growth factor (PDGF)-B into healing patellar ligament. Gene Ther 5:1165-1170, 1998.
58. Nakamura N, Timmermann SA, Hart DA, et al: A comparison of in vivo gene delivery methods for antisense therapy in ligament healing. Gene Ther 5:1455-1461, 1998.
59. 1 encoding gene. Spine 24:2419-2425, 1999.
60. Nishida K, Kang JD, Suh JK, et al: Adenovirus-mediated gene transfer to nucleus pulposus cells: Implication for the treatment of intervertebral disc degeneration. Spine 23:2437-2443, 1998.
61. Nita I, Ghivizzani SC, Galea-Lauri J, et al: Direct gene delivery to synovium: An evaluation of potential vectors in vitro and in vivo. Arthritis Rheum 39:820-828, 1996.
62. Niyibizi C, Baltzer A, Lattermann C, et al: Potential role for gene therapy in the enhancement of fracture healing. Clin Orthop 355(Suppl):S148-S153, 1998.
63. Otani K, Nita I, Macaulay W, et al: Suppression of antigen-induced arthritis by gene therapy. J Immunol 156:3558-3562, 1996.
64. Oyama M, Tatlock A, Fukuta S, et al: Retrovirally transduced bone marrow stromal cells isolated from osteogenesis imperfecta (oim) mice persist in bone and retain the ability to form cartilage and bone after extended passaging. Gene Ther 6:321-329, 1999.
65. Pelletier JP, Caron J, Evans CH, et al: In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy. Arthritis Rheum 40:1012-1019, 1997.
66. Pereira RF, O'Hara MD, Laptev AV, et al: Marrow stromal cells as a source of progenitor cells for non-hematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proc Natl Acad Sci USA 95:1142-1147, 1998.
67. Pittenger MF, Mackay AM, Beck SC, et al: Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147, 1999.
68. Robbins PD, Ghivizzani SC: Viral vectors for gene delivery. Pharmacol Ther 80:35-47, 1998.
69. Sandhu JS, Gorczynski RM, Waddell J, et al: Effect of interleukin-6 secreted by engineered human stromal cells on osteoclasts in human bone. Bone 24:217-227, 1999.
70. Schwab JH, Anderle SK, Brown RR, et al: Pro- and anti-inflammatory effects of interleukin-1 in recurrence of bacterial cell wall-induced arthritis in rats. Infect Immunol 59:4436-4442, 1989.
71. 1 gene into articular chondrocytes. J Orthop Res In Press.
72. Smith P, Shuler FD, Georgescu HI, et al: Genetic enhancement of matrix synthesis by articular chondrocytes: Comparison of different growth factor genes in the presence or absence of interleukin-1. Arthritis Rheum In Press.
73. Stefanovic-Racic M, Stadler J, Evans CH: Nitric oxide and arthritis. Arthritis Rheum 36:1036-1044, 1993.
74. Tomita T, Hashimoto H, Tomita N, et al: In vivo direct gene transfer into articular cartilage by intraarticular injection mediated by HVJ (sendai) virus and liposomes. Arthritis Rheum 40:901-906, 1997.
75. Whalen JD, Lechman ER, Carlos CA, et al: Adenoviral transfer of viral IL-10 gene peri-articularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws. J Immunol 162:3625-3632, 1999.
76. Wooley PH, Whalen JD, Chapman DL, et al: The effect of interleukin-1 receptor antagonist protein on type II collagen-induced arthritis and antigen-induced arthritis in mice. Arthritis Rheum 36:1305-1312, 1993.
77. Yovandich J, O'Malley B, Sikes M, et al: Gene transfer to synovial cells by intraarticular administration of plasmid DNA. Hum Gene Ther 6:603-610, 1995.